Human papillomavirus (HPV) vaccine market shaping roadmap

The roadmap is a foundational tool of Gavi’s market shaping strategy, with the purpose of articulating a long-term vision and market strategy designed to align market shaping objectives and target outcomes across the Alliance partners; define a set of interventions to reach these objectives and target outcomes; and inform procurement strategies and decisions. The roadmap focuses on Gavi-supported countries, which consist of the currently Gavi-eligible countries (54 countries plus India); and former and never Gavi-eligible middle-income countries that are now eligible for support under Gavi’s Middle-Income Countries (MICs) Approach (46 countries). It takes a long-term view of the market, starting from 2023 through the next ten years. While market projections cover until 2035, proposed interventions focus on the next five years, which are critical for the Alliance’s market shaping strategy.